Richard D. Kim - Concepedia

Author

Richard D. Kim

Also Known As

R. D. Kim, Richard D Kim, Richard D. Kim

Publications

462

Citations

H-Index

Concepts

All Affiliations

Richard D. Kim is an author at Moffitt Cancer Center specializing in tumor biology, pathology, and cancer cell biology.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	35
2	Pathology	1	1	35
3	Pharmacology	1	1	35
4	Cancer Cell Biology	1	1	35
5	Cancer Therapeutics	1	1	35

Richard D. Kim

Publications

439

Citations

H-Index

Page 1

	Year	Citations
First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma Richard D. Kim, Debashis Sarker, Tim Meyer, Cancer Discovery	2019	239
Acquired On-Target Clinical Resistance Validates FGFR4 as a Driver of Hepatocellular Carcinoma Megan Hatlen, Oleg Schmidt-Kittler, Cori Ann Sherwin, Cancer Discovery	2019	106
Updated dose escalation results for ReFocus, a first-in-human study of highly selective FGFR2 inhibitor RLY-4008 in cholangiocarcinoma and other solid tumors. Mitesh J. Borad, Alison M. Schram, Richard D. Kim, Journal of Clinical Oncology Prior FgfriPathologyOther Solid TumorsFirst-in-human StudyTumor Biology	2023	35
Improving identification of differentially expressed genes in microarray studies using information from public databases Richard D. Kim, Peter J. Park Genome biology	2004	33
CrossChip: a system supporting comparative analysis of different generations of Affymetrix arrays Sek Won Kong, Kyu‐Baek Hwang, Richard D. Kim, Computer applications in the biosciences	2005	16
Abstract IA006: Clinical activity of lirafugratinib (RLY-4008), a highly selective FGFR2 inhibitor, in patients with advanced FGFR2-altered solid tumors: The ReFocus study Alison M. Schram, Vivek Subbiah, Chih‐Yi Liao, Molecular Cancer Therapeutics	2023	10

Page 1